GlassScriptPhysician profile
Thomas Frank Milisits
NPI 1275111395
$15,982.02
in general payments reported to CMS, 2019-2025
27 companies · $9,713 in 2025
The $9,713 reported for 2025 was more than what 96% of Foot & Ankle Surgery providers received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $38.09 · 2024: $6,231 · 2025: $9,713.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $8,750 · Food and Beverage: $7,232.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $8,749.81 |
| Food and Beverage | $7,232.21 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Acumed LLC | $4,363.66 | 2024-2025 | Osteomed, Acumed, Acumed |
| Orthofix Medical, INC. | $2,382.58 | 2024 | Truelok, Physio-Stim |
| Paragon 28, INC. | $1,894.42 | 2024-2025 | Portfolio, Phantom Fibula Nail, Monkey Rings |
| Treace Medical Concepts, INC. | $1,300.93 | 2025 | |
| Exactech, INC. | $981.03 | 2025 | |
| Trimed, INC. | $879.10 | 2025 | |
| Vilex LLC | $778.96 | 2025 | Hintermann |
| Stryker Corporation | $635.97 | 2023-2025 | Infinity Adaptis, Augment Injectable, Ortholoc 3di |
| Smith+Nephew, INC. | $527.96 | 2024-2025 | Grafix Pl, Stravix, Stravix Pl |
| Zimmer Biomet Holdings, INC. | $287.01 | 2024 | Tapestry, Juggerknotless Soft Anchor, Quattro |
| Alexion Pharmaceuticals, INC. | $265.82 | 2025 | Strensiq |
| Kerecis Limited | $247.21 | 2024-2025 | Kerecis Surgiclose, Kerecis Omega3 Marigen, Kerecis Graftguide |
| Ibsa Pharma INC. | $201.15 | 2024-2025 | Licart, Tirosint, Flector |
| Restor3d, INC. | $176.58 | 2025 | |
| Peter Brasseler Holdings, LLC | $172.19 | 2025 |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biocomposites INC | $170.89 | 2024 | |
| Anika Therapeutics, INC. | $155.00 | 2025 | Integrity Implant |
| Henry Schein, INC. | $140.39 | 2025 | |
| Pacira Pharmaceuticals Incorporated | $125.00 | 2025 | Exparel |
| Solventum Corporation | $99.50 | 2025 | Activ.A.C., V.A.C.Ulta |
| Forma Medical | $48.83 | 2025 | Optimalmtp |
| Bioventus LLC | $38.72 | 2025 | Exogen Ultrasound Bone Healing System |
| Paratek Pharmaceuticals, INC. | $32.86 | 2025 | Nuzyra |
| Averitas Pharma INC. | $24.49 | 2025 | Qutenza |
| Eclipse Technology Solutions INC. | $19.94 | 2025 | |
| Vertex Pharmaceuticals Incorporated | $16.24 | 2025 | |
| Paladin Technology Solutions | $15.59 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thomas Milisits listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.